Radiation retinopathy; a journey with intravitreal injections through 12.5 years of treatment and follow-up

KARATAS E., SAATCİ A. O.

Retina-Vitreus, cilt.30, sa.1, ss.74-80, 2021 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.37845/ret.vit.2021.30.13
  • Dergi Adı: Retina-Vitreus
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.74-80
  • Anahtar Kelimeler: Afl ibercept, Bevacizumab, Dexamethasone implant, Radiation retinopathy, Ranibizumab
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

© 2021 Gazi Eye Foundation. All rights reserved.The records of a patient who has been treated for radiation retinopathy following the administration of external radiotherapy for Graves ophthalmopathy was reviewed retrospectively.A total of 60 intravitreal injections were administered into the patient's right eye during a period of 12.5 years (triamcinolone acetonide, pegaptanib, bevacizumab, ranibizumab,afl ibercept,dexamethazone implant) . Visual acuity of the right eye remained the same as baseline visual acuity of 0.2 with the Snellen chart during the follow up. Macular edema related to radiation retinopathy could not be fully controlled during the course of follow -up . Various agents were administered during the follow-up period due to persistent nature of the macular edema. The clinical course refl ects the relatively negative character of the disease and also proves that radiation maculopathy is a very resistant disease requiring almost continuous intravitreal therapy.